References
- Filipo R, Mancini P, Nostro G. Meniere's disease and autoimmunity. Ann N Y Acad Sci 1999; 830: 299–305.
- Fransen E, Verstreken M, Verhagen WI, et al. High prevalence of symptoms of Meniere's disease in three families with a mutation in the COCH gene. Hum Mol Genet 1999; 8: 1425–9.
- De Kok YI, Bom SJ, Brunt TM, et al. A Pro51Ser mutation in COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects. Hum Mol Genet 1999; 8: 361–6.
- Bowman CA, Nelson RA. Human leukocytic antigens in autoimmune sensorineural hearing loss. Laryngo-scope 1987; 97: 7–9.
- Matsuki K, Harad T, Juji T, Kanzaki J, Koga K, Toriyama M. Human leukocyte antigens in childhood unilateral deafness. Arch Otolaryngol Head Neck Surg 1998; 115: 46–7.
- Cao MY, Thonnard J, Deggouj N, et al. HLA class-II associated susceptibility in idiopathic progressive sen-sorineural hearing loss. Ann Otol Rhinol Laryngol 1996; 105: 628–33.
- Flasza J, Turowski G, Reron E. Class I HLA antigens in patients with sensorineural hearing loss: preliminary report. Otolaryngol Pol 1997; 51: 216–22.
- Xenellis J, Morrison AW, McCloweskey D, Festenstein H. HLA antigens in pathogenesis of Meniere's disease. J Laryngol Otol 1986; 200: 21–4.
- Evans KL, Baldwin DL, Bainbridge D, Morrison AW. Immune status in patients with Meniere's disease. Arch Otorhinolaryngol 1988; 245: 287–92.
- Bumm P, Muller EC, Grimm-Muller U, Schlimok G. T-lymphocyte subpopulation and HLA-DR antigens in hearing loss of vestibular neuropathy, Meniere's dis-eases and Bell's palsy. Laryngorhinootologie 1991; 70: 260–6.
- Koyama S, Mitsuishi Y, Bibee K, Watanabe I, Terasaki PI. HLA association with Meniere's disease. Acta Otolaryngol (Stockh) 1993; 113: 575–8.
- Arweiler DJ, Jahnke K, Grosse-Wildde H. Meniere disease as an autoimmune hereditary disease. Laryn-gorhinootologie 1995; 74: 512–5.
- Aultman D, Adamashvili I, Kamalakar Y, et al. Solu-ble HLA in human body fluids. Human Immunol 1999; 60: 239–44.
- Committee on Hearing and Equilibrium. Guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Arch Otolaryngol Head Neck Surg 1995; 113: 163–7.
- Grundschober N, Rufer A, Sanchez-Mazas A, et al. Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs. Tissue Antigens 1997; 49: 612–23.
- Inostroza J, Munoz P, Espinoza R, et al. Quantitation of soluble HLA class I heterodimers and beta-2 mi-croglobulin in patients with active pulmonary tuber-colosis. Hum Immunol 1994; 40: 179–84.
- Thursz M, Howard CT, Greenwood BM, Hill AVS. Heterozygote advantage for HLA class II type in hep-atitis B virus infection. Nat Genet 1997; 17: 11–2.
- Zavazava N, Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 1996; 2: 1005–10.
- Falck CS, Schendel DJ. HLA-C revisited. Ten years of change. Immunol Res 1997; 16: 203–14.
- Iwai H, Tomoda K, Sugiura K, Inaba M, Ikehara S, Yamashita T. T cells infiltrating from the circulation proliferate in the endolymphatic sac. Ann Otol Rhinol Laryngol 1999; 12: 1146–50.